Home / News / India News / Article /
Review process begins for WHO listing of Covaxin: Bharat Biotech
Updated On: 13 July, 2021 09:54 AM IST | Hyderabad | IANS
Bharat Biotech Chairman and Managing Director Krishna Ella said all s required for EUL of Covaxin have been submitted to WHO as of July 9
Listen to this article :
A vial of Covaxin | File Pic
Bharat Biotech on Monday said that it has submitted all documents to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its Covid-19 vaccine Covaxin and the review process has commenced.
Bharat Biotech Chairman and Managing Director Krishna Ella said all documents required for EUL of Covaxin have been submitted to WHO as of July 9.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT